Suven Pharma: Cabinet clears Advent's acquisition of Suven Pharma for Rs 9,589 crore

The Indian government has approved a foreign direct investment (FDI) proposal worth Rs. 9,589 crore in Suven Pharmaceuticals Limited. Private equity firm Advent International will acquire a 50.1% stake in the company for Rs. 6,313 crore, with plans to launch an open offer for an additional 26%.

Related Keywords

Cyprus ,India ,Kozhikode ,Kerala ,Venkat Jasti ,Suven Pharma ,Cabinet Committee On Economic Affairs ,Advent International ,Suven Pharmaceuticals ,Advent Group ,Indian Company ,Berhyanda Ltd ,Indian School Of Business ,Advent International Corporation ,Offering College ,Partners Lps ,Healthcare Management Analytics Programme ,Cabinet Committee ,Economic Affairs ,Prime Minister Narendra Modi ,Suven Pharmaceuticals Limited ,Hyderabad Based Suven Pharmaceuticals ,Healthcare Expertise ,Advent Funds ,Limited Partners ,International Corporation ,Fdi ,